SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001558370-22-014511
Filing Date
2022-09-21
Accepted
2022-09-21 08:00:13
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A tmb-20220921xdefa14a.htm DEFA14A 19246
2 GRAPHIC tmb-20220921xdefa14a001.jpg GRAPHIC 5932
  Complete submission text file 0001558370-22-014511.txt   28861
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

IRS No.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEFA14A | Act: 34 | File No.: 001-38247 | Film No.: 221255027
SIC: 2834 Pharmaceutical Preparations